Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed. The domestic pharmaceutical industry clocked negligible growth of 0.2 per......
The intention of the government is to cap prices of drugs that are essential and which the public widely uses. The government may consider rationalising trade margins of antibiotics after having......
Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales. Illustration: Uttam Ghosh/Rediff.com Sales volume of pharmaceutical......
FMCG, durables, pharma firms say they remain unclear about transition gains and losses The goods and services tax (GST), the biggest tax reform since Independence, is likely to lead to much......